Skip to main content
ORASURE TECHNOLOGIES INC logo

ORASURE TECHNOLOGIES INC — Investor Relations & Filings

Ticker · OSUR ISIN · US68554V1089 LEI · 529900GNNJPNM4XHXQ77 US Manufacturing
Filings indexed 1,018 across all filing types
Latest filing 2021-04-01 Director's Dealing
Country US United States of America
Listing US OSUR

About ORASURE TECHNOLOGIES INC

https://www.orasure.com/

OraSure Technologies, Inc. develops, manufactures, and distributes diagnostic products and sample collection tools. The company specializes in non-invasive technologies, particularly oral fluid-based solutions, to decentralize diagnostics and improve healthcare access. Its portfolio includes point-of-care and over-the-counter rapid tests for infectious diseases such as HIV and COVID-19. A notable achievement is the development of the first over-the-counter at-home HIV test. Through its subsidiaries, OraSure also provides sample management solutions for the collection of biological samples used in genomic, metabolomic, and microbiome research, serving healthcare providers, researchers, and consumers.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2021-04-01 English
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, dated March 1, 2021, by OraSure Technologies, Inc. It announces the release of the company's consolidated financial results for the full year and quarter ended December 31, 2020, and includes a press release, prepared remarks for a conference call, and an investor presentation. The document itself is an announcement of these materials and does not contain the full financial statements or detailed financial analysis. The presence of a press release and investor presentation attached as exhibits further supports that this is a current report announcing earnings results rather than the earnings release itself. Therefore, the document is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement and does not contain the full earnings release or detailed financial data within the text itself.
2021-03-01 English
10-K
Annual Report FY 2020
2021-03-01 English
SC 13G
Major Shareholding Notification
2021-02-16 English
SEC SCHEDULE 13G
Major Shareholding Notification
2021-02-12 English
Major Shareholding Notification 2021
Major Shareholding Notification
2021-02-11 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.